Medical News: Advancing Regenerative Medicine in Vietnam-Japan Partnership
Lạc Việt Friendship Hospital System Collaborates with Kyushu Advanced Welfare Medicine Association on Stem Cell Technology
On the morning of December 6, 2025, at Thang Long Lạc Việt International Hospital, the Lạc Việt Friendship Hospital System (LVFH) held an online discussion with representatives from the Kyushu Advanced Welfare Medicine Promotion Association (Japan) to explore cooperation opportunities in stem cell technology and regenerative medicine.
The Japanese delegation included Mr. Nishiza Seiki, President of the Association, and Prof. Chiba Shunmei, a renowned expert in stem cells, neurology, and regenerative medicine, who pioneered 3D stem cell culture technology. The Kyushu Association is a leading organization responsible for inspecting and licensing hospitals in the Kyushu region for the application of regenerative medicine.
It brings together top scientists and specialists in fields such as mesenchymal stem cells derived from obstetric by-products (umbilical cord, placenta), iPS cell therapy, gene therapy, and molecular targeted drugs.
Key attendees from the Lạc Việt Hospital System included Mr. Đỗ Trọng Thủy (CEO of Lạc Việt Group) and M.D., Level II Specialist Nguyễn Mạnh Tưởng (Deputy Director of Thang Long Lạc Việt International Hospital). Prof. Dr. Lê Văn Quảng, LVFH’s Professional Advisor, and Director of K Hospital and Director of the Cancer Prevention Research Institute, also participated.
Transfer of 3D Stem Cell Technology and Long-Term Cooperation Strategy
During the meeting, the two parties discussed crucial topics, including the exchange and transfer of advanced Japanese technologies in 3D stem cell culture and application, the potential use of stem cells to support the treatment of cancer and degenerative diseases.
Prof. Chiba Shunmei expressed a strong desire to transfer the technology to Vietnam: “We are committed to accompanying the Lạc Việt Friendship Hospital System through the training process to ensure all procedures meet Japanese standards.”
Mr. Đỗ Trọng Thủy, representing LVFH, affirmed the system’s readiness to send staff to Japan for hands-on training and experience. The objective is to systematically acquire the technology to serve Vietnamese patients effectively and safely.
The two sides also agreed to jointly organize an International Scientific Workshop on new advancements in stem cell treatment, tentatively scheduled for March 2026 in Hanoi, featuring experts from both countries. Prof. Dr. Lê Văn Quảng praised this cooperation, viewing it as an opportunity to update knowledge and expand international collaboration for the practical benefit of patients.
This initial cooperation lays the groundwork for future long-term collaboration, aiming to apply advanced stem cell technology to treat chronic and degenerative diseases, and cancer. The shared goal is to reduce the burden of illness, improve patients’ quality of life, and expand access to cutting-edge treatments for Vietnamese people right at home, minimizing financial pressure and optimizing the long-term treatment journey.
